Results 1 to 10 of about 1,097,021 (302)

Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities

open access: yesFrontiers in Oncology, 2022
Hepatocellular carcinoma is one of the leading causes of cancer mortality globally, and its incidence is increasing. Immune checkpoint therapy has revolutionized the treatment of hepatocellular carcinoma over the past few years.
Qingqing Xie   +4 more
doaj   +1 more source

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors

open access: yesZhongliu Fangzhi Yanjiu, 2021
Cardiotoxicity is a serious complication of antineoplastic drugs. With the continuous development of antineoplastic drugs, immune checkpoint inhibitors have been used in the treatment of a variety of cancers.
YU Lin   +3 more
doaj   +1 more source

Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?

open access: yesFrontiers in Immunology, 2022
Immune checkpoint inhibitor (ICI) is one of the most important tumor treatment methods. Although the therapeutic efficiency of immune checkpoint inhibitor mono-therapy is limited, the combination of chemotherapy plus immune checkpoint inhibitors has ...
Xinye Qian   +5 more
doaj   +1 more source

Research Advances in Intracranial Radiotherapy Combined with Immune Checkpoint Inhibitors on Lung Cancer Brain Metastasis

open access: yesZhongliu Fangzhi Yanjiu, 2020
In recent years, immunotherapy has been continuously developed, and the safety and efficacy of immune checkpoint inhibitors combined with intracranial radiotherapy for melanoma brain metastasis have been initially recognized.
HE Qian, REN Qinglan
doaj   +1 more source

Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy

open access: yesVaccines, 2023
Hepatitis B virus (HBV) infection is the main risk factor for the development of hepatocellular carcinoma (HCC), the most common type of liver cancer, with high incidence and mortality worldwide.
Jin Zhang   +5 more
doaj   +1 more source

Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review [PDF]

open access: yesIntestinal Research, 2023
Immune checkpoint inhibitors have dramatically revolutionized the therapeutic landscape for patients with advanced malignancies. Recently, convincing evidence has shown meaningful influence of gut microbiome on human immune system.
Sung Wook Hwang   +2 more
doaj   +1 more source

Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients

open access: yesKidney International Reports, 2020
Introduction: Kidney transplant (Ktx) recipients are excluded from clinical trials of immune checkpoint inhibitors. The aim of this systematic review was to assess the safety of immune checkpoint inhibitors among Ktx patients.
Sandhya Manohar   +4 more
doaj   +1 more source

Challenges of Immune Checkpoint Inhibitors in Treatment of Non-small Cell Lung Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2019
With the gradually in-depth research of immune checkpoint, the checkpoint inhibitors, such as programmed death-1(PD-1) inhibitors, programmed death–ligand 1(PD-L1) inhibitors and cytotoxic T lymphocyte-associated protein-4(CTLA-4) inhibitors, had made ...
LI Xiangmin, FAN Zaiwen
doaj   +1 more source

Novel Delivery Systems for Checkpoint Inhibitors

open access: yesMedicines, 2019
Checkpoint inhibition (CPI) therapies have been proven to be powerful clinical tools in treating cancers. FDA approvals and ongoing clinical development of checkpoint inhibitors for treatment of various cancers highlight the immense potential of ...
Purushottam Lamichhane   +10 more
doaj   +1 more source

Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case series

open access: yesJournal for ImmunoTherapy of Cancer, 2019
Background In non-small cell lung cancer, response rates to chemotherapy given after immune checkpoint inhibitors has been reported to be higher compared to response rates to chemotherapy given before immune checkpoint inhibitors.
Rayan Alsuwaigh   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy